| MeSH term | MeSH ID | Detail |
|---|---|---|
| Gastritis | D005756 | 27 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Sickle Cell Trait | D012805 | 4 associated lipids |
| beta-Thalassemia | D017086 | 5 associated lipids |
Total
4
2,2-DIMETHYLBUTYRIC ACID
2,2-DIMETHYLBUTYRIC ACID is a lipid of Fatty Acyls (FA) class. The involved functions are known as Fermentation, Process, Intestinal Absorption, Energy Metabolism and Proteolysis. 2,2-dimethylbutyric acid often locates in host and Hepatic. The related lipids are Propionate, Butyrates, n-Butyrate, Valerates and blood lipid.
Cross Reference
Introduction
To understand associated biological information of 2,2-DIMETHYLBUTYRIC ACID, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 2,2-DIMETHYLBUTYRIC ACID?
There are no associated biomedical information in the current reference collection.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,2-DIMETHYLBUTYRIC ACID
PubChem Associated disorders and diseases
What pathways are associated with 2,2-DIMETHYLBUTYRIC ACID
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 2,2-DIMETHYLBUTYRIC ACID?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 2,2-DIMETHYLBUTYRIC ACID?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 2,2-DIMETHYLBUTYRIC ACID?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 2,2-DIMETHYLBUTYRIC ACID?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with 2,2-DIMETHYLBUTYRIC ACID?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 2,2-DIMETHYLBUTYRIC ACID
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Knapp E et al. | Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents. | 2016 | Am. J. Hematol. | pmid:26661045 |
| Dai Y et al. | Therapeutic fetal-globin inducers reduce transcriptional repression in hemoglobinopathy erythroid progenitors through distinct mechanisms. | 2016 | Blood Cells Mol. Dis. | pmid:26603726 |
| Mehraei M et al. | Target-based drug discovery for [Formula: see text]-globin disorders: drug target prediction using quantitative modeling with hybrid functional Petri nets. | 2016 | J Bioinform Comput Biol | pmid:27431020 |
| Patthamalai P et al. | A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia. | 2014 | Blood | pmid:24652964 |
| Reid ME et al. | A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. | 2014 | Am. J. Hematol. | pmid:24677033 |
| Inati A et al. | A phase 2 study of HQK-1001, an oral fetal haemoglobin inducer, in β-thalassaemia intermedia. | 2014 | Br. J. Haematol. | pmid:24224649 |
| Kutlar A et al. | A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease. | 2013 | Am. J. Hematol. | pmid:23828223 |
| Fucharoen S et al. | A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia. | 2013 | Br. J. Haematol. | pmid:23530969 |
| Kutlar A et al. | A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease. | 2012 | Am. J. Hematol. | pmid:22887019 |
| Bhatia MS et al. | Synthesis, characterization and quantification of simvastatin metabolites and impurities. | 2011 Jul-Sep | Sci Pharm | pmid:21886906 |
| Perrine SP et al. | Evaluation of safety and pharmacokinetics of sodium 2,2 dimethylbutyrate, a novel short chain fatty acid derivative, in a phase 1, double-blind, placebo-controlled, single-dose, and repeat-dose studies in healthy volunteers. | 2011 | J Clin Pharmacol | pmid:21422239 |
| Terse PS et al. | Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley rats. | 2011 | Toxicol Pathol | pmid:21558467 |
| Wang H et al. | In-situ XAFS studies of Mn12 molecular-cluster batteries: super-reduced Mn12 clusters in solid-state electrochemistry. | 2011 | Chem Asian J | pmid:21265025 |
| Perrine SP et al. | Fetal globin gene inducers: novel agents and new potential. | 2010 | Ann. N. Y. Acad. Sci. | pmid:20712788 |
| Galanello R and Origa R | Beta-thalassemia. | 2010 | Orphanet J Rare Dis | pmid:20492708 |
| Barrios-González J and Miranda RU | Biotechnological production and applications of statins. | 2010 | Appl. Microbiol. Biotechnol. | pmid:19820926 |
| Parise RA et al. | Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma. | 2008 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:18155649 |
| Martin FP et al. | Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. | 2008 | Mol. Syst. Biol. | pmid:18197175 |
| Martin FP et al. | Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. | 2008 | Mol. Syst. Biol. | pmid:18628745 |
| Martin FP et al. | A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. | 2007 | Mol. Syst. Biol. | pmid:17515922 |
| Nguyen TD et al. | Novel short chain fatty acids restore chloride secretion in cystic fibrosis. | 2006 | Biochem. Biophys. Res. Commun. | pmid:16472777 |
| Chakov NE et al. | New polynuclear manganese clusters from the use of the hydrophobic carboxylate ligand 2,2-dimethylbutyrate. | 2005 | Inorg Chem | pmid:15962962 |
| Stiefl N and Baumann K | Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique. | 2003 | J. Med. Chem. | pmid:12672239 |
| Tang YL et al. | [Chemical components of essential oils from the herb of Ligularia virgaurea]. | 2003 | Zhongguo Zhong Yao Za Zhi | pmid:15139106 |
| Cejka J et al. | Simvastatin. | 2003 | Acta Crystallogr C | pmid:12909768 |
| Krishna S et al. | Differential effects of short-chain fatty acids on head and neck squamous carcinoma cells. | 2002 | Laryngoscope | pmid:12150517 |
| Uchiyama N et al. | Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: identification of metabolites by gas chromatography/mass spectrometry. | 1991 Jul-Sep | Eur J Drug Metab Pharmacokinet | pmid:1814736 |
| pmid: |